Department of Health and Human Services May 22, 2020 – Federal Register Recent Federal Regulation Documents
Results 1 - 11 of 11
Request for Nominations on the Tobacco Products Scientific Advisory Committee
The Food and Drug Administration (FDA) is requesting nominations for a nonvoting representative of the interests of the tobacco growers to serve on the Tobacco Products Scientific Advisory Committee (TPSAC), in the Center for Tobacco Products. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups. A nominee may either be self- nominated or nominated by an organization. In addition, FDA is requesting that any industry organizations interested in participating in the selection of a nonvoting representative of the interests of the tobacco growers industry to serve on the TPSAC, notify FDA in writing. Nominations will be accepted for either the representative to serve on TPSAC or for the selection group effective with this notice.
Availability of Program Application Instructions for Medicare Improvements for Patients and Providers Act (MIPPA) Program Funds
The purpose of MIPPA funding is to enhance statewide and local coalition building focused on outreach, education, and one-to-one assistance activities to Medicare beneficiaries likely to be eligible for the Low Income Subsidy program (LIS) or the Medicare Savings Programs (MSP), above and beyond those regular activities planned in response to other funding. ACL will provide funding to State Health Insurance Assistance Programs (SHIP), Area Agencies on Aging (AAA), and Aging and Disability Resource Center (ADRC). ACL seeks plans from applicants that will describe how the MIPPA funds will be used for outreach, education, and one-on-one application assistance over the next year. ACL requests that applicants submit a one (1) year state plan with specific project strategies to: 1. Enhance their one-on-one assistance, education, and outreach efforts to eligible Medicare beneficiaries regarding their preventive, wellness, and limited income benefits; 2. Describe how the SHIP, AAA, and ADRC efforts will be coordinated to provide outreach to beneficiaries with limited incomes statewide including rural areas and tribal entities; 3. Review and update previous MIPPA plans to reflect successes achieved to date and direct their efforts to enhance and expand their MIPPA outreach activities; and 4. Set performance goals, taking into account the MIPPA Performance Measures (PMs) implemented in Grant Year 2019 [Performance Measures include: Overall MIPPA Contacts; Overall Persons Reached through Outreach; MIPPA Target Populations (Under 65, Rural, Native American, English as a Secondary Language); and Contacts with Applications Submitted]. Additionally, programs should ensure MIPPA counselors familiarity with integrated care programs that support beneficiaries' independence at home and in the community, including Programs of All-Inclusive Care for the Elderly, Medicare Advantage Special Needs Plans and Supplemental benefits, and other integrated care programs for Medicare and Medicaid dual eligible beneficiaries. Applicant plans should go above and beyond those regular activities planned in response to other funding. State agencies may prepare either one statewide plan or separate plans for each eligible agency. Announcement Type: Initial. Funding Opportunity Number: CIP-MI-20-001. Statutory Authority: The statutory authority for grants under this program announcement is contained in the 2006 Reauthorization of the Older Americans ActSection 202 and the Medicare Improvements for Patients and Providers Act of 2008Section 119, Public Law (Pub. L.) 110-275 as amended by the Patient Protection and Affordable Care Act of 2010 (Affordable Care Act), reauthorized by the American Taxpayer Relief Act of 2012 (ATRA), the Protecting Access to Medicare Act of 2014, and the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), the Bipartisan Budget Act of 2018, and the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020. Catalog of Federal Domestic Assistance (CFDA) Number: 93.071.
Prospective Grant of an Exclusive Patent License: Antibody-Based Therapy for the Treatment of CD20 Expressing Lymphomas
The National Heart, Lung, and Blood Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Retargeted Therapeutics, a corporation incorporated under the laws of the state of Delaware.
Agency Information Collection Activities; Proposed Collection; Comment Request; State Petitions for Exemption From Preemption
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of our reporting requirements contained in existing FDA regulations governing state petitions for exemption from preemption.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
